The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
Researchers at Brigham and Women’s Hospital and Massachusetts Institute of Technology have developed a new type of nanoparticle, which can be taken orally and gets successfully absorbed through the digestive tract. The nanoparticles ...
Tags: nanoparticle, Medicine
Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...
Packaging Coordinators (PCI) has announced plans to expand its clinical packaging business operations by opening a new facility in Rockford with an investment of about $8m. The new building will be located in the Logistics industrial park ...
History glassworks originates from February 1903, when the noble and Balkashin I.Stolkind based on the former glass shops in the village of Mount Solar created the company "Trading house and Balkashin Stolkinda." After World War II the ...
Baxter International has initiated a voluntary recall of one lot of Nitroglycerin in 5% Dextrose injection due to particulate matter found in one vial. If infused, particulate matter could lead to potential venous and/or arterial ...
Tags: Dextrose Injection, Medicine
US-based research and development biotechnology firm Boston Strategics has entered into a new drug development partnership with Fujifilm Pharmaceuticals USA (FPHU), a global pharmaceutical development center of Japan's Fujifilm Corporation. ...
Tags: Oncology Drugs, Fujifilm Pharma
A new project, co-funded with EUR8.5m from the European Commission is underway to accelerate the development of new vaccines, drugs and microbicides to fight against many poverty-related diseases such as tuberculosis (TB), HIV, malaria, ...
Tags: Poverty Related Diseases, Medicine
Canada-based ImStar Therapeutics has announced the selection of IMS-088 as its lead drug candidate for the treatment of amyotrophic lateral sclerosis. IMS-088 is a novel, small-molecule drug that stems from the discovery of a new target ...
The price of a single bitcoin reached US$1,000 Wednesday, demonstrating a new level of interest for the digital currency that earlier this year was trading for just $30. Bitcoin trading surpassed the $1,000 mark on the Tokyo-based Mt. ...
Anti-malarial treatments that act on a new target have the potential to cure, prevent and block the transmission of the disease, U.S. researchers said. The as-yet undeveloped treatments would target an enzyme essential for the growth and ...
Tags: Anti-malarial, treatment, act, target, parasite
Posted in Testing Services by Chris Newmarker on November 25, 2013 The FDA is telling 23andMe to stop marketing its Personal Genomic Service tests. The FDA’s move is but another sign that the regulator is increasingly concerned ...
Tags: 23andMe, DNA, Hit, FDA, warning letter
UK-based drug discovery and development firm Summit has formed a strategic alliance with the University of Oxford in order to further strengthen its utrophin modulator program for the treatment of the fatal muscle wasting disease duchenne ...
One year after more than 60 died and 750 were sickened by fungal meningitis, the U.S. Senate passed a law to help ensure compound drug safety, officials say. The Drug Quality and Security Act reflects a bipartisan, bicameral effort to ...
The sorption behaviour of 20 organic micropollutants originating in wastewater – for which there are little or no experimentally determined data – is assessed by means of sediment column experiments. Organic pollutants derived ...
Tags: Sorption Behaviour, Wastewater-Originated Micropollutants, Groundwater